KCNB1 and Alzheimer disease: Work from our lab further indicated that prolonged Dasatinib treatment in 3xTg-AD mice decreased brain inflammation and Aβ load and reduced behavioral deficit caused by the oxidation of integrin-α5-KCNB1 complexes [64].